Brain scans guide new depression treatment trial
NCT ID NCT06408246
Summary
This study is testing if adding the medication guanfacine to a standard antidepressant (sertraline) can help people with depression, especially those who also have trouble with thinking and focus. Researchers will use brain scans and cognitive tests to see how the treatment affects brain networks. The goal is to see if this approach leads to better recovery from depressive symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford Psychiatry and Behavioral Sciences Department
RECRUITINGPalo Alto, California, 94305, United States
-
University of Illinois at Chicago
RECRUITINGChicago, Illinois, 60607, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.